Zobrazeno 1 - 10
of 7 856
pro vyhledávání: '"Cyclin D"'
Autor:
Zhang W; Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA., Liu Y; Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA., Jang H; Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Nussinov R; Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. Electronic address: nussinor@mail.nih.gov.
Publikováno v:
Structure (London, England : 1993) [Structure] 2024 Aug 08; Vol. 32 (8), pp. 1269-1280.e2. Date of Electronic Publication: 2024 May 03.
Autor:
Simoneschi D; Department of Biochemistry and Molecular Pharmacology, Grossman School of Medicine, New York University, New York, NY, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2022 Nov 25; Vol. 378 (6622), pp. 845. Date of Electronic Publication: 2022 Nov 24.
Autor:
Cardona-Benavides IJ; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca., Misiewicz-Krzeminska I; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw., Rojas EA; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca., De Ramón C; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca., Sanz-Solas A; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca., Isidro I; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca., Quwaider D; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca., López-Guerrero AM; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca., Cuadrado M; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca., Calasanz MJ; Clínica Universidad de Navarra, Centro de Investigaciones Biomédicas Aplicadas (CIMA), Instituto de Investigación Sanitaria de Navarra, (IdiSNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Rosiñol L; Hospital Clinic of Barcelona, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona., Martínez-López J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain; Spanish National Cancer Research Center (CNIO), Madrid, Spain; Hematology Department, Hospital 12 de Octubre, Medicine Department, Complutense University Madrid., San Miguel JF; Clínica Universidad de Navarra, Centro de Investigaciones Biomédicas Aplicadas (CIMA), Instituto de Investigación Sanitaria de Navarra, (IdiSNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Mateos MV; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Corchete LA; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Gutiérrez NC; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Spain; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC). normagu@usal.es.
Publikováno v:
Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 877-887. Date of Electronic Publication: 2024 Mar 01.
Autor:
Ziegler DV; Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Parashar K; Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Fajas L; Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; INSERM, Montpellier, France. Electronic address: lluis.fajas@unil.ch.
Publikováno v:
Seminars in cancer biology [Semin Cancer Biol] 2024 Jan; Vol. 98, pp. 51-63. Date of Electronic Publication: 2023 Dec 20.
Autor:
Yuan H; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, P.R. China., Li S, Zhao Z; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, P.R. China., Wang Y; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, P.R. China.
Publikováno v:
Organogenesis [Organogenesis] 2023 Dec 31; Vol. 19 (1), pp. 2285836. Date of Electronic Publication: 2023 Nov 30.
Autor:
Gwak SH; Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Korea., Lee J; Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Korea., Oh E; Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Korea., Lee D; Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Korea.; R&D Center, NovMetaPharma Co., Ltd., Pohang, 37668, Korea., Han W; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Korea., Kim J; Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Korea., Kim KT; Generative Genomics Research Center, Global Green Research & Development Center, Handong Global University, Pohang, 37554, Korea.
Publikováno v:
Oncology research [Oncol Res] 2023 Dec 28; Vol. 32 (2), pp. 421-432. Date of Electronic Publication: 2023 Dec 28 (Print Publication: 2023).
Autor:
Knight H; School of Cardiovascular and Metabolic Medicine and Sciences, British Heart Foundation Centre of Research Excellence (H.K., M.K., H.L.H.G., J.C., O.R.), King's College London, United Kingdom., Abis G; Division of Biosciences, Institute of Structural and Molecular Biology, University College London, United Kingdom (G.A.)., Kaur M; School of Cardiovascular and Metabolic Medicine and Sciences, British Heart Foundation Centre of Research Excellence (H.K., M.K., H.L.H.G., J.C., O.R.), King's College London, United Kingdom., Green HLH; School of Cardiovascular and Metabolic Medicine and Sciences, British Heart Foundation Centre of Research Excellence (H.K., M.K., H.L.H.G., J.C., O.R.), King's College London, United Kingdom., Krasemann S; Institute of Neuropathology, University Medical Centre Hamburg-Eppendorf, Germany (S.K., K.H.)., Hartmann K; Institute of Neuropathology, University Medical Centre Hamburg-Eppendorf, Germany (S.K., K.H.)., Lynham S; Proteomics Core Facility, Centre of Excellence for Mass Spectrometry (S.L.), King's College London, United Kingdom., Clark J; School of Cardiovascular and Metabolic Medicine and Sciences, British Heart Foundation Centre of Research Excellence (H.K., M.K., H.L.H.G., J.C., O.R.), King's College London, United Kingdom., Zhao L; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, United Kingdom (L.Z.)., Ruppert C; Universities of Giessen and Marburg Lung Center Giessen Biobank, Justus-Liebig-University Giessen, Germany (C.R.)., Weiss A; Department of Internal Medicine, Justus-Liebig-University Giessen, Giessen, Member of the German Center for Lung Research (DZL), Germany (A.W., R.T.S.)., Schermuly RT; Department of Internal Medicine, Justus-Liebig-University Giessen, Giessen, Member of the German Center for Lung Research (DZL), Germany (A.W., R.T.S.)., Eaton P; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (P.E.)., Rudyk O; School of Cardiovascular and Metabolic Medicine and Sciences, British Heart Foundation Centre of Research Excellence (H.K., M.K., H.L.H.G., J.C., O.R.), King's College London, United Kingdom.
Publikováno v:
Circulation research [Circ Res] 2023 Dec 08; Vol. 133 (12), pp. 966-988. Date of Electronic Publication: 2023 Nov 13.
Autor:
Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Looze EJ; Division of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Thavaneswaran S; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., van Berge Henegouwen JM; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., van der Wijngaart H; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Sebastian L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lee CK; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands., Lin FP; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands., Thomas DM; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia., Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Oct 01; Vol. 153 (7), pp. 1413-1422. Date of Electronic Publication: 2023 Jul 10.
Autor:
Mohamed FZ; Chemistry Department (Biochemistry Branch), Faculty of Science, Zagazig University, Zagazig, Egypt., Eid SA; Chemistry Department, Faculty of Science, Port Said University, Port Said, Egypt., Elghareb MS; Chemistry Department, Faculty of Science, Port Said University, Port Said, Egypt., Abas AM; Chemistry Department (Biochemistry Branch), Faculty of Science, Zagazig University, Zagazig, Egypt. dr_shmma@yahoo.com.
Publikováno v:
Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2023 Oct; Vol. 512 (1), pp. 300-318. Date of Electronic Publication: 2023 Dec 13.
Autor:
Caudron-Herger M; Division of RNA Biology & Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Diederichs S; Division of RNA Biology & Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. s.diederichs@dkfz.de.; Division of Cancer Research, Department of Thoracic Surgery, Medical Center-University of Freiburg, University of Freiburg, German Cancer Consortium (DKTK)-Partner Site Freiburg, Freiburg, Germany. s.diederichs@dkfz.de.
Publikováno v:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2021 Aug 19; Vol. 6 (1), pp. 311. Date of Electronic Publication: 2021 Aug 19.